Search Results - "Forte, C P"

The major human rhinovirus receptor is ICAM-1 by Greve, J M, Davis, G, Meyer, A M, Forte, C P, Yost, S C, Marlor, C W, Kamarck, M E, McClelland, A

“…The major human rhinovirus receptor has been identified with monoclonal antibodies that inhibit rhinovirus infection. These monoclonal antibodies recognize a…”
Get more information

Comparison of a daily and alternate-day photobiomodulation protocol in the prevention of oral mucositis in patients undergoing radiochemotherapy for oral cancer: a triple-blind, controlled clinical trial by Oliveira, F-M, Borges, M-M, Malta, C-E, Moura, J-F, Forte, C-P, Barbosa, J-V, Silva, P-G, Dantas, T-S

“…Preventive Photobiomodulation Therapy (PBMT) significantly reduces oral mucositis (OM) severity in patients undergoing Radiochemotherapy (RCT) for the…”
Get full text

Mechanisms of receptor-mediated rhinovirus neutralization defined by two soluble forms of ICAM-1 by GREVE, J. M, FORTE, C. P, MARLOR, C. W, MEYER, A. M, HOOVER-LITTY, H, WUNDERLICH, D, MCLELLAND, A

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Model for Mammalian Metallothionein Structure by Boulanger, Yvan, Goodman, Christopher M., Forte, Carla P., Fesik, Stephen W., Armitage, Ian M.

“…The results of physicochemical studies of mammalian metallothioneins are summarized and used to propose a model of the protein. The primary structures of all…”
Get full text

A T-cell-selective interleukin 2 mutein exhibits potent antitumor activity and is well tolerated in vivo by Shanafelt, Armen B, Lin, Yue, Shanafelt, Marie-Claude, Forte, Carla P, Dubois-Stringfellow, Nathalie, Carter, Christopher, Gibbons, Jacqueline A, Cheng, Shu-lan, Delaria, Katherine A, Fleischer, Richard, Greve, Jeffrey M, Gundel, Robert, Harris, Kathleen, Kelly, Ruth, Koh, Beth, Li, Ying, Lantz, Lori, Mak, Polly, Neyer, Lauri, Plym, Mary Jane, Roczniak, Steve, Serban, Daniel, Thrift, John, Tsuchiyama, Linda, Wetzel, Monte, Wong, Mel, Zolotorev, Alya

“…Human interleukin 2 (IL-2; Proleukin) is an approved therapeutic for advanced-stage metastatic cancer; however, its use is restricted because of severe…”
Get full text

An Immune Cell-Selective Interleukin 4 Agonist by Shanafelt, Armen B., Forte, Carla P., Kasper, James J., Sanchez-Pescador, Lisa, Wetzel, Monte, Gundel, Robert, Greve, Jeffrey M.

“…Interleukin 4 (IL-4) is a pleiotropic cytokine. Of the cell types responsive to IL-4, T cells express one IL-4 receptor (IL-4R) type, IL-4Rα /IL-2Rγ (class I…”
Get full text

Interleukin-4 variant (BAY 36-1677) selectively induces apoptosis in acute lymphoblastic leukemia cells by Srivannaboon, Kleebsabai, Shanafelt, Armen B., Todisco, Elisabetta, Forte, Carla P., Behm, Frederick G., Raimondi, Susana C., Pui, Ching-Hon, Campana, Dario

“…Interleukin 4 (IL-4) suppresses the growth of acute lymphoblastic leukemia (ALL) cells, but its clinical usefulness is limited by proinflammatory activity due…”
Get full text